Mark Architectural Lighting Introduces SLOT 6 Recessed with Care222® Technology

January 3, 2023 Scott Bailey

SLOT 6 Recessed with Care222® technology reduces active pathogens* on non-porous surfaces and in the air using Ushio Care222® far-UVC disinfection** technology. SLOT 6 features a mercury-free far-UVC excimer lamp that contains a patented short pass filter for narrow band 222nm emission. This removes wavelengths that penetrate the living tissue in skin or deeper than the top layer of the cornea.

Blending modern aesthetics with unparalleled optical performance, the Slot 6 LED luminaire creates simple lines of light. Energy efficiency, design flexibility and seamless control make this recessed fixture a brilliant addition to any design. Available in 4’ or 8’ lengths, SLOT 6 can be used to create continuous runs that elevate ceilings in offices, lobbies, hotels and beyond. Slot 6 delivers up to 1200 lumens per foot at an excellent color quality of up to 90CRI.

Care222® technology uses filtered 222 nanometer UV-C light to inactivate a variety of bacteria and viruses* in spaces like conference rooms, break rooms and rest rooms. A patented short pass filter ensures only a narrow band of 222nm UV-C light is emitted, which does not penetrate living tissue in the skin or past tear layers in the eye.  SLOT 6 can be used in occupied spaces when properly installed and operated.

Learn more about SLOT 6 with Care222 Technology.

*Refer to product specification sheets at marklighting.com/SLOT6 for efficacy claims and claim substantiation regarding specific products and pathogens.

**All references to “disinfection” are referring generally to the reduction of bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency. Bioburden reduction is a function of fixture run time and the distance to the UV light source, airflow, room size, shadow areas and/or other factors, and the level of reduction will vary within a specific space. This fixture is not intended for use in the cure, mitigation or prevention of disease and is not certified or approved for use as a medical device by the FDA. It is the obligation of the end-user to consult with a qualified Professional Engineer and a Certified Industrial Hygienist, if applicable, to determine whether this fixture meets the applicable requirements for performance, code compliance, safety (including safety and hazard alerting signs), suitability and effectiveness for use in a particular application design. In no event will Acuity Brands Lighting be responsible for any loss resulting from any use of this fixture in an application design.

Trademarks referenced are the property of their respective owners.

Previous Article
Mark Architectural Lighting Honored with 2023 LEDs Magazine BrightStar Award
Mark Architectural Lighting Honored with 2023 LEDs Magazine BrightStar Award

Mark Architectural Lighting Honored with 2023 LEDs Magazine BrightStar Award

Next Article
MARK ARCHITECTURAL LIGHTING LAUNCHES UPDATED SLOT 2 & SLOT 4 PENDANT, SURFACE, & WALL LUMINAIRES
MARK ARCHITECTURAL LIGHTING LAUNCHES UPDATED SLOT 2 & SLOT 4 PENDANT, SURFACE, & WALL LUMINAIRES

Atlanta, GA, November 22, 2022 – MARK Architectural Lighting (www.marklighting.com), an established leader ...